The usefulness of [131I]-metaiodobenzylguanidine ([131I]-MIBG) scintigraphy performed one week after administration in diagnosing pheochromocytoma

International Journal of Urology

Volumn 6, Issue 7, 1999, Pages 331-336

  Takahashi, Nobuyoshi ^a   Suzuki, Tadashi ^a   Yamaya, Kanemitsu ^b   Funyu, Tomihisa ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b Oyokyo Kidney Research Institute   (Japan)

Author keywords

131I metaiodobenzylguanidine scintigraphy; Non pheochromocytoma; Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; PHEOCHROMOCYTOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCINTIGRAPHY; ADOLESCENT; ADRENAL TUMOR; AGED; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PHEOCHROMOCYTOMA; RADIOPHARMACEUTICALS;

EID: 0032588046     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.1999.00079.x     Document Type: Article

References (15)

1. 131I] iodobenzylguanidine. J. Nucl. Med. 1980; 21: 349-53.
2. 2 Sisson JC, Frager MS, Valk TW et al. Scintigraphic localization of pheochromocytoma. N. Engl. J. Med. 1981; 305: 12-17.
3. 3 Wieland DM, Brown LE, Rogers WL et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J. Nucl. Med. 1981; 22: 22-31.
4. 4 Shapiro B, Copp JE, Sisson JC, Eyle PL, Wallis J, Beierwaltes WH, Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: Experience in 400 cases. J. Nucl. Med. 1985; 26: 576-85.
5. 5 Tenenbaum F, Lumbroso J, Schlumberger M et al. Comparison of radiolabeled octreotide and metaiodobezylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J. Nucl. Med. 1995; 36: 1-6.
6. 131I]-metaiodobenzylguanidine scintigraphy with urinary and plasma catecholamine determinations in the diagnosis of pheochromocytoma. Klin. Wschr. 1985; 63: 627-30.
7. 131I]-MIBG) scintigraphy in Japan. Jap. J. Nucl. Med. 1986; 23: 145-52.
8. 8 Dae MW, Marco TD, Botvinick EHO et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts: Implications for clinical studies. J. Nucl. Med. 1992; 33: 1444-50.
9. 9 Geatti O, Shapiro B, Shulkin B, Hutchinson R, Sisson JC. Gastrointestinal iodine-131-meta-iodobenzylguanidine activity. Am. J. Physiol. Imaging 1988; 3: 188-91.
10. 10 Lindberg S, Fjalling M, Jacobsson L, Jansson S, Tisell LE. Methodology and dosimetory in adrenal medullary imaging with iodine-131 MIBG. J. Nucl. Med. 1988; 29: 1638-43.
11. 131I]-metaiodobenzy guanidine (MIBG). Hormon to Rinsho, 1987; 35: 495-9.
12. 12 Troncone L, Rufini V, Danza FM et al. Radioiodinated metaiodobenzylguanidine (I-MIBG) scintigraphy in neuroblastoma. A review of 160 studies. J. Nucl Med. Allied Sci. 1990; 34: 279-88.
13. 131I]-MIBG) for the localization of suspected pheochromocytoma. Nucl. Med. Commun. 1989; 10: 467 75.
14. 14 Khafagi FA, Shapiro B, Fig LM, Mallette S, Sisson JC. Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. J. Nucl. Med. 1989; 30: 481-9.
15. 123I]-MIBG scintigraphy. Radiology 1985; 155:789 92.